GLAXO
Invest with MTF
Invest Now
Invest in GlaxoSmithKline Pharmaceuticals with 3.25X leverage
Performance
- Low
- ₹2,542
- High
- ₹2,675
- 52 Week Low
- ₹1,968
- 52 Week High
- ₹3,516
- Open Price₹2,550
- Previous Close₹2,516
- Volume356,548
- 50 DMA₹2,466.63
- 100 DMA₹2,551.73
- 200 DMA₹2,626.78
Investment Returns
- Over 1 Month + 10.57%
- Over 3 Month + 1.35%
- Over 6 Month -1.06%
- Over 1 Year + 18.78%
Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!
GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 43.5
- PEG Ratio
- 2.3
- Market Cap Cr
- 44,434
- P/B Ratio
- 26
- Average True Range
- 81.01
- EPS
- 59.37
- Dividend Yield
- 1.6
- MACD Signal
- -8.04
- RSI
- 67.35
- MFI
- 68.09
GlaxoSmithKline Pharmaceuticals Financials
GlaxoSmithKline Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,622.90
+
106.7
(4.24%)
- Bearish Moving Average 3
- Bullish Moving Average 13
- 20 Day
- ₹2,440.07
- 50 Day
- ₹2,466.63
- 100 Day
- ₹2,551.73
- 200 Day
- ₹2,626.78
Resistance and Support
2613.17
- R3 2,818.13
- R2 2,746.57
- R1 2,684.73
- S1 2,551.33
- S2 2,479.77
- S3 2,417.93
GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
GlaxoSmithKline Pharmaceuticals F&O
About GlaxoSmithKline Pharmaceuticals
- NSE Symbol
- GLAXO
- BSE Symbol
- 500660
- Managing Director
- Mr. B Akshikar
- ISIN
- INE159A01016
Similar Stocks to GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals FAQs
GlaxoSmithKline Pharmaceuticals share price is ₹2,622 As on 11 February, 2026 | 02:38
The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹44433.5 Cr As on 11 February, 2026 | 02:38
The P/E ratio of GlaxoSmithKline Pharmaceuticals is 43.5 As on 11 February, 2026 | 02:38
The PB ratio of GlaxoSmithKline Pharmaceuticals is 26 As on 11 February, 2026 | 02:38
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.